(2,2-Dimethyltetrahydro-2H-pyran-4-yl)methanamine, 95.0%, 250mg

3,5-DIFLUORO-2-NITROTOLUENE, 98.0%, 5g

(S)-1-(4-Cyanophenyl)ethanamine, 95.0%, 100mg

Plan stress-free PLPOLi 20x/0.40 IOS objective for iScope incident polarization, no cover glass correction. Working distance 5.8 mm

Ethyl 2-(2-oxo-1,3-oxazolidin-3-yl)acetate, 95%, 250mg

7-(Tert-butyl) 4-ethyl 7H-pyrrolo[2,3-d]pyrimidine-4,7-dicarboxylate, 98%, 50mg

4-Benzylpiperidin-4-ol, 100mg

5-Bromo-7-fluoro-benzofuran-2-carboxylic acid, 100mg

2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

Cyclopropanecarboxylic Acid>98.0%(GC)(T)25mL

(1S,4S,5S)-tert-Butyl 5-amino-2-azabicyclo[2.2.1]heptane-2-carboxylate, 95%, 1g

1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide, 95.0%, 100mg

5-fluoro-1,2,3,4-tetrahydro-1,8-naphthyridin-2-one, 95.0%, 250mg